Grand Rounds are presented live every 3rd Tuesday of each month. Can't catch it live? Check out the Grand Rounds On Demand archive for our past presentations.

Changes in Clinical Diagnostics and Tracking Infectious Diseases

Presented on .

When it comes to tracking infectious diseases and outbreaks, determining who is infected with a particular pathogen is the first step in solving the puzzle and stopping the spread of the disease. Traditionally, culture testing has been the primary means of identifying the specific pathogen. With this method, cultures must be evaluated in a lab setting, and results can take two or three days. Culture-independent diagnostic tests (CIDTs) are a new method for diagnosing infections, and they are often used to identify foodborne illness. CIDTs work by detecting the presence of a specific genetic sequence or antigen of a germ.

These newer tests are faster, and results are available much sooner than with traditional culture tests. However, CIDTs don’t identify the exact organism that caused the illness, and they don’t provide some of the more detailed information that culture tests can. For example, CIDTs don’t tell us what specific strain of an illness someone has, or how it may respond to antibiotics. Using only CIDTs makes it more difficult to connect individual infections to the same strain and to identify outbreaks.

This session of Public Health Grand Rounds discusses how CIDTs are changing the landscape of diagnosing infectious disease. Speakers will also discuss how the tests are evolving, and how some states are adapting to using CIDTs in their public health systems.

Beyond the Data

In this session of Beyond the Data, Dr. Phoebe Thorpe and Alicia Cronquist, RN, MPH, discuss culture-independent diagnostic tests (CIDTs) and how they are changing the landscape of tracking infectious diseases. Tune in to hear how these tests are different from traditional laboratory cultures, and learn how some states like Colorado are addressing the challenges of using CIDTs in the field.

Presented By
Christopher Braden, MD
Deputy Director
National Center for Emerging and Zoonotic Infectious Diseases, CDC
Alicia Cronquist, RN, MPH
Foodborne Disease Program Manager, Communicable Disease Branch
Colorado Department of Public Health and Environment
Bradford Spring, BS
Vice President, Regulatory Affairs and Compliance
BD Life Sciences
John Besser, PhD
Deputy Chief, Enteric Diseases Laboratory Branch,
Division of Foodborne, Waterborne, and Environmental Diseases

National Center for Emerging and Zoonotic Infectious Diseases, CDC
Facilitated By
John Iskander, MD, MPH
Scientific Director
Phoebe Thorpe, MD, MPH
Deputy Scientific Director
Susan Laird, MSN, RN
Communications Director
Enjoyed this Presentation?
Social_govd

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Social_govd

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up

Social_govdSign Up

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Continuing Education
This session is available for Continuing Education (CE). Register here using the course information below.

CDC Course Code: PHGR10
CPE UAN: 0387-0000-16-108-H04-P

For more information, see Grand Rounds Continuing Education.

You May Also Like
March 2014, HIV/STD/TB
doctor in front of xrays

Tuberculosis is a global cause of morbidity and mortality. In most cases, TB can be treated and cured with a combination of multiple drugs. However, TB bacteria can develop resistance to multiple drugs. Hear how advances in diagnostic and treatment options are reducing the overall morbidity from multi-drug resistant TB.

November 2014, General Science
doctor talking to young patient

While some organ transplantations are life-saving procedures, serious illness and death can occur from undetected infections in donor organs and tissues. New advances exist that make transplants safer. Learn what CDC and its partners are doing to actively reduce the risk of unusual transplant-associated infections.

Page last reviewed: February 28, 2018
Content source: